Flibanserin Versus Placebo in Premenopausal Women With HSDD
Clinical trial NCT00491829 · COMPLETED
Trial details
- NCT number
- NCT00491829
- Sponsor
- Sprout Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2009-03-01
- Enrollment
- 945
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.